Comparative effectiveness of TNF inhibitor vs IL-6 receptor inhibitor as monotherapy or combination therapy with methotrexate in biologic-experienced patients with rheumatoid arthritis: An analysis from the CorEvitas RA Registry

OBJECTIVE: Randomized controlled trials (RCTs) in biologic-naïve rheumatoid arthritis (RA) patients with high disease activity and inadequate response/intolerance to methotrexate have shown interleukin-6 (IL-6) receptor inhibitors (IL-6Ri) to be superior to tumor necrosis factor inhibitors (TNFi) as...

Descripción completa

Detalles Bibliográficos
Autores principales: Sebba, Anthony, Bingham, Clifton O., Bykerk, Vivian P., Fiore, Stefano, Ford, Kerri, Janak, Jud C., Pappas, Dimitrios A., Blachley, Taylor, Dave, Swapna S., Kremer, Joel M., Yu, Miao, Choy, Ernest
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345054/
https://www.ncbi.nlm.nih.gov/pubmed/37060528
http://dx.doi.org/10.1007/s10067-023-06588-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345054/
https://www.ncbi.nlm.nih.gov/pubmed/37060528
http://dx.doi.org/10.1007/s10067-023-06588-7

Ejemplares similares